Fair Trade Commission Conducts On-Site Investigation of Daewoong Pharmaceutical for Alleged Unfair Support to Affiliates
The Korea Fair Trade Commission has detected signs that Daewoong Pharmaceutical unfairly supported its group affiliates and has launched an on-site investigation.
According to industry sources on the 31st, the Fair Trade Commission sent investigators to Daewoong Pharmaceutical the previous day to secure materials related to unfair internal support.
The Fair Trade Commission has recently been monitoring internal transactions within mid-sized business groups and has identified allegations of unfair internal transactions by multiple companies, leading to ongoing investigations.
Hot Picks Today
Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive)
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- U.S. Stocks Up 1% on War Negotiation Hopes... Will Korea Recover Recent Losses? [Good Morning Market]
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
At the beginning of the year, the Fair Trade Commission announced in its work plan that it would focus on closely monitoring illicit wealth transfers for management succession, unfair support that undermines the competitiveness of independent and small businesses, and unfair support of insolvent affiliates.
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2023042017373296095_1681979852.jpg)
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
